Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Yurdaydin C, Keskin O, Yurdcu E, Çalişkan A, Önem S, Karakaya F, Kalkan Ç, Karatayli E, Karatayli S, Choong I, Apelian D, Koh C, Heller T, Idilman R, Bozdayi AM, Glenn JS. Yurdaydin C, et al. Among authors: karatayli e. Hepatology. 2022 Jun;75(6):1551-1565. doi: 10.1002/hep.32259. Epub 2021 Dec 23. Hepatology. 2022. PMID: 34860418 Clinical Trial.
The first identified hepatitis B virus vaccine escape mutation in Turkey.
Kutlu T, Soycan LY, Karatayli E, Türkyilmaz AR, Yurdaydin C, Bozdayi AM. Kutlu T, et al. Among authors: karatayli e. J Clin Virol. 2006 Feb;35(2):201-2. doi: 10.1016/j.jcv.2005.09.003. Epub 2005 Oct 17. J Clin Virol. 2006. PMID: 16230046 No abstract available.
Entecavir treatment of chronic hepatitis D.
Kabaçam G, Onder FO, Yakut M, Seven G, Karatayli SC, Karatayli E, Savas B, Idilman R, Bozdayi AM, Yurdaydin C. Kabaçam G, et al. Among authors: karatayli e, karatayli sc. Clin Infect Dis. 2012 Sep;55(5):645-50. doi: 10.1093/cid/cis459. Epub 2012 May 9. Clin Infect Dis. 2012. PMID: 22573857
Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C. Karatayli E, et al. Among authors: karatayli sc. Antivir Ther. 2013;18(1):77-85. doi: 10.3851/IMP2294. Epub 2012 Aug 10. Antivir Ther. 2013. PMID: 22878399 Clinical Trial.
35 results